Dreicer R - Search Results

1

Second-generation interferons for cancer: clinical targets.

Borden EC, Lindner D, Dreicer R, Hussein M, Peereboom D. Borden EC, et al. Among authors: dreicer r. Semin Cancer Biol. 2000 Apr;10(2):125-44. doi: 10.1006/scbi.2000.0315. Semin Cancer Biol. 2000. PMID: 10936063 Review.

2

Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer.

Clark PE, Peereboom DM, Dreicer R, Levin HS, Clark SB, Klein EA. Clark PE, et al. Among authors: dreicer r. Urology. 2001 Feb;57(2):281-5. doi: 10.1016/s0090-4295(00)00914-6. Urology. 2001. PMID: 11182337 Clinical Trial.

3

Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancer.

Dreicer R, Klein EA. Dreicer R, et al. Semin Oncol. 2001 Aug;28(4 Suppl 15):45-8. doi: 10.1016/s0093-7754(01)90154-x. Semin Oncol. 2001. PMID: 11685728 Clinical Trial.

4

Brain metastases from bladder carcinoma: presentation, treatment and survival.

Mahmoud-Ahmed AS, Suh JH, Kupelian PA, Klein EA, Peereboom DM, Dreicer R, Barnett GH. Mahmoud-Ahmed AS, et al. Among authors: dreicer r. J Urol. 2002 Jun;167(6):2419-22. J Urol. 2002. PMID: 11992049

5

Locally advanced prostate cancer.

Klein EA, Kupelian PA, Dreicer R, Peereboom D, Zippe C. Klein EA, et al. Among authors: dreicer r. Curr Treat Options Oncol. 2001 Oct;2(5):403-11. doi: 10.1007/s11864-001-0045-1. Curr Treat Options Oncol. 2001. PMID: 12057103 Review.

6

Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: toxicity and immunological effects.

Hutson TE, Molto L, Mekhail T, Elson P, Finke J, Tannenbaum C, Borden E, Dreicer R, Olencki T, Bukowski RM. Hutson TE, et al. Among authors: dreicer r. Clin Cancer Res. 2003 Apr;9(4):1354-60. Clin Cancer Res. 2003. PMID: 12684404 Clinical Trial.

7

Phase II trial of GM-CSF + thalidomide in patients with androgen-independent metastatic prostate cancer.

Dreicer R, Klein EA, Elson P, Peereboom D, Byzova T, Plow EF. Dreicer R, et al. Urol Oncol. 2005 Mar-Apr;23(2):82-6. doi: 10.1016/j.urolonc.2004.08.013. Urol Oncol. 2005. PMID: 15869991 Clinical Trial.

8

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: dreicer r. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

9

Phase I trial of three-weekly docetaxel, carboplatin and oral lenalidomide (Revlimid) in patients with advanced solid tumors.

Kalmadi S, Davis M, Dowlati A, O'Keefe S, Cline-Burkhardt M, Pelley RJ, Borden E, Dreicer R, Bukowski R, Mekhail T. Kalmadi S, et al. Among authors: dreicer r. Invest New Drugs. 2007 Jun;25(3):211-6. doi: 10.1007/s10637-006-9025-4. Epub 2006 Nov 11. Invest New Drugs. 2007. PMID: 17103043 Clinical Trial.

10

Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study.

Magi-Galluzzi C, Zhou M, Reuther AM, Dreicer R, Klein EA. Magi-Galluzzi C, et al. Among authors: dreicer r. Cancer. 2007 Sep 15;110(6):1248-54. doi: 10.1002/cncr.22897. Cancer. 2007. PMID: 17674353 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page